InnoPharmax Inc. (TPEX:4172)
Taiwan · Delayed Price · Currency is TWD 9.51
-0.43 (-4.33%)
Oct 20, 2026, 1:53 PM CST
InnoPharmax Market Cap
InnoPharmax has a market cap or net worth of 1.19 billion as of October 20, 2026. It is the 32,538th most valuable company in the world and the 1,948th biggest in Taiwan. Its market cap has decreased by 42.90% in one year.
Market Cap
1.19B
Enterprise Value
207.63M
Revenue
67.47M
Global Rank
Country Rank
#1,948 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since September 13, 2012, InnoPharmax's market cap has decreased from 1.54B to 1.19B, a decrease of -22.90%. That is a compound annual growth rate of -1.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 1.19B | -34.23% |
| Dec 31, 2025 | 1.81B | 3.38% |
| Dec 31, 2024 | 1.75B | 5.76% |
| Dec 29, 2023 | 1.65B | 62.70% |
| Dec 30, 2022 | 1.02B | -32.67% |
| Dec 30, 2021 | 1.51B | 15.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TSH Biopharm Corporation | 2.13B |
| Johnson Chemical Pharmaceutical Works | 2.11B |
| Tien Liang BioTech | 1.75B |
| GeneFerm Biotechnology | 1.20B |
| Excelsior Biopharma | 1.11B |
| Prince Pharmaceutical | 1.07B |
| Anxo Pharmaceutical | 902.23M |
| DV Biomed | 871.69M |